logo
Plus   Neg
Share
Email

Nippon Steel & Sumitomo Metal, Mitsui's JV With Rio Tinto To Invest In Australia

Nippon Steel & Sumitomo Metal Corp. or NSSMC and Mitsui & Co., Ltd. announced Monday that their joint venture with mining giant Rio Tinto Plc (RTNTF,RIO,RIO.L, RTPPF), Robe River Iron Associates, has decided to invest in the development of new iron ore deposits in Western Australia. These deposits are the Mesa B/C/H in the Robe Valley mine and the Deposit C/D in the West Angelas mine in the Pilbara region of Western Australia.

In the Robe River JV, Rio Tinto holds 53%, Mitsui holds 33%, and NSSMC has a 14% stake.

The total investment in the subject development is estimated to be $1.55 billion or equivalent to approximately 170.1 billion yen, of which NSSMC and Mitsui will invest $216 million or approximately 23.8 billion yen and $510 million or approximately 56.1 billion yen , respectively, in proportion to each of their equity stakes.

The existing deposits in both Robe Valley mine and West Angelas mine, currently in operation, are nearing the end of their lifespan. The Robe River J/V will develop these new deposits utilizing the existing rail and port infrastructure, with the objective of sustaining current rates of iron ore production as existing mines decline.

Subject to government and environmental approvals, development of new deposits is expected to start next year, and first ore is currently anticipated from 2021.

NSSMC and Mitsui will work together with Rio Tinto through the Robe River J/V to stably procure and supply iron ore, for which further demand is expected.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
MillerCoors LLC has filed a lawsuit against Anheuser-Busch Companies LLC, part of Anheuser-Busch InBev, alleging that Anheuser-Busch's ad campaigns associating MillerCoors' products, Miller Lite and Coor Light, with corn syrup is "false and misleading." During the Super Bowl, ABInBev ran an advertising campaign that mocked Miller Lite and Coors Light use corn syrup in brewing. Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab. The European Union on Wednesday ordered Alphabet Inc.'s Google to pay an antitrust fine of 1.49 billion euros for abusing its dominant position in the online search advertising intermediation market by preventing competition. This is the third antitrust fine by the EU against Google and it represents 1.29 percent of the tech giant's turnover in 2018.
Follow RTT